TRCT
OSTX

Tower Research Capital (TRC)’s OS Therapies Inc OSTX Stock Holding History

Tower Research Capital (TRC)’s Portfolio OSTX Stock Details OSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,179
Closed -$5.89K – 5725
2026
Q1 		$5.89K Buy
4,179
+4,091
+4,649% +$5.81K ﹤0.01% 4093
2025
Q4 		$123 Sell
88
-4,079
-98% -$7.36K ﹤0.01% 5029
2025
Q3 		$8.17K Buy
4,167
+1,617
+63% +$3.2K ﹤0.01% 4061
2025
Q2 		$4.79K Buy
+2,550
New +$4.29K ﹤0.01% 4266

Other funds holding OSTX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HFS
Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Tower Research Capital (TRC)'s OSTX Position: Q2 2026 in Review

Tower Research Capital (TRC) sold out of OS Therapies Inc (OSTX) in Q2 2026, closing a stake of 4,179 shares — an estimated $5.89K sold.

Tower Research Capital (TRC) first reported a position in OSTX in Q2 2025 and held it in 4 quarters. The position peaked at $8.17K in Q3 2025. 29 funds tracked by Wall St. Rank hold OSTX as of Q2 2026.

  • Tower Research Capital (TRC) reported no remaining OS Therapies Inc position as of Q2 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 4,179 OS Therapies Inc shares in Q2 2026, an estimated $5.89K.
  • Tower Research Capital (TRC) first reported a position in OS Therapies Inc in Q2 2025 and held it in 4 quarters.
  • Tower Research Capital (TRC)'s OS Therapies Inc position peaked at $8.17K in Q3 2025.
  • 29 funds tracked by Wall St. Rank held OS Therapies Inc as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.